Dean Capital Management trimmed its position in shares of Maximus, Inc. (NYSE:MMS – Free Report) by 48.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 19,743 shares of the health services provider’s stock after selling 18,440 shares during the period. Dean Capital Management’s holdings in Maximus were worth $1,704,000 at the end of the most recent reporting period.
A number of other large investors have also added to or reduced their stakes in the company. Richardson Financial Services Inc. lifted its holdings in Maximus by 29.6% in the 4th quarter. Richardson Financial Services Inc. now owns 451 shares of the health services provider’s stock worth $39,000 after buying an additional 103 shares in the last quarter. Farther Finance Advisors LLC grew its stake in shares of Maximus by 69.0% during the fourth quarter. Farther Finance Advisors LLC now owns 284 shares of the health services provider’s stock valued at $25,000 after acquiring an additional 116 shares in the last quarter. Parkside Financial Bank & Trust increased its position in shares of Maximus by 13.4% during the fourth quarter. Parkside Financial Bank & Trust now owns 1,268 shares of the health services provider’s stock worth $109,000 after acquiring an additional 150 shares during the last quarter. GAMMA Investing LLC increased its position in shares of Maximus by 13.8% during the fourth quarter. GAMMA Investing LLC now owns 1,522 shares of the health services provider’s stock worth $131,000 after acquiring an additional 185 shares during the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of Maximus by 0.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider’s stock worth $2,351,000 after acquiring an additional 221 shares in the last quarter. 97.21% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of research analysts recently commented on MMS shares. Wall Street Zen raised Maximus from a “hold” rating to a “buy” rating in a report on Saturday, June 6th. Weiss Ratings downgraded Maximus from a “hold (c)” rating to a “hold (c-)” rating in a report on Wednesday, May 20th. Finally, Zacks Research lowered Maximus from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 27th. Two investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat, Maximus has a consensus rating of “Hold”.
Maximus Stock Performance
Shares of Maximus stock opened at $55.72 on Friday. The company has a debt-to-equity ratio of 0.87, a quick ratio of 2.21 and a current ratio of 2.21. Maximus, Inc. has a 1 year low of $56.92 and a 1 year high of $100.00. The firm’s 50-day simple moving average is $63.15 and its 200-day simple moving average is $75.10. The firm has a market cap of $2.93 billion, a PE ratio of 8.34 and a beta of 0.58.
Maximus (NYSE:MMS – Get Free Report) last posted its quarterly earnings results on Thursday, May 7th. The health services provider reported $2.07 EPS for the quarter, topping analysts’ consensus estimates of $1.98 by $0.09. The business had revenue of $1.31 billion during the quarter, compared to the consensus estimate of $1.32 billion. Maximus had a return on equity of 25.10% and a net margin of 7.02%.The company’s revenue for the quarter was down 4.1% compared to the same quarter last year. During the same period last year, the firm earned $2.01 earnings per share. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. Equities analysts forecast that Maximus, Inc. will post 8.43 earnings per share for the current fiscal year.
Maximus Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Monday, June 1st. Stockholders of record on Friday, May 15th were issued a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date was Friday, May 15th. Maximus’s payout ratio is 19.76%.
Maximus Profile
Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.
Featured Articles
- Five stocks we like better than Maximus
- Credo Technologies Accelerates AI—Its Stock Price Will Follow
- Qualcomm Goes All-In: The $10B Bet to Crush NVIDIA
- Jabil Just Gave Investors a Stronger Reason to Buy the Dip
- CarMax In Reverse? Why You Should Buy Now Before the Big Catalysts Emerge
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS – Free Report).
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.
